Publication | Closed Access

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Sickle Cell DiseasePediatric HematologyLong-term Follow-up ResultsHematologyTranslational ResearchMedicine